|
1
|
Doi Y and Paterson DL:
Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care
Med. 36:74–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Girmenia C, Viscoli C, Piciocchi A,
Cudillo L, Botti S, Errico A, Sarmati L, Ciceri F, Locatelli F,
Giannella M, et al: Management of carbapenem resistant Klebsiella
pneumoniae infections in stem cell transplant recipients: An
Italian multidisciplinary consensus statement. Haematologica.
100:e373–e376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vardakas KZ, Matthaiou DK, Falagas ME,
Antypa E, Koteli A and Antoniadou E: Characteristics, risk factors
and outcomes of carbapenem-resistant Klebsiella pneumoniae
infections in the intensive care unit. J Infect. 70:592–599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Girometti N, Lewis RE, Giannella M,
Ambretti S, Bartoletti M, Tedeschi S, Tumietto F, Cristini F,
Trapani F, Gaibani P and Viale P: Klebsiella pneumoniae bloodstream
infection: Epidemiology and impact of inappropriate empirical
therapy. Medicine (Baltimore). 93:298–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderson MJ and Janoff EN: Klebsiella
endocarditis: Report of two cases and review. Clin Infect Dis.
26:468–474. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srinivas KH, Sharma R, Agrawal N and
Manjunath CN: Silent destruction of aortic and mitral valve by
Klebsiella pneumoniae endocarditis. BMJ Case Rep.
2013.pii:bcr2013200704, 2013.
|
|
7
|
Yong MS, Coffey S, Prendergast BD, Marasco
SF, Zimmet AD, McGiffin DC and Saxena P: Surgical management of
tricuspid valve endocarditis in the current era: A review. Int J
Cardiol. 202:44–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Satlin MJ, Jenkins SG and Walsh TJ: The
global challenge of carbapenem-resistant Enterobacteriaceae in
transplant recipients and patients with hematologic malignancies.
Clin Infect Dis. 58:1274–1283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prébet T, Devillier R, Fürst S, Vey N and
Blaise D: Allogeneic hematopoietic SCT and mechanical heart valve:
Feasibility of reduced toxicity myeloablative conditioning. Bone
Marrow Transplant. 45:1574–1575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fecher AM, Birdas TJ, Haybron D, Papasavas
PK, Evers D and Caushaj PF: Cardiac operations in patients with
hematologic malignancies. Eur J Cardiothorac Surg. 25:537–540.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saußele S and Silver RT: Management of
chronic myeloid leukemia in blast crisis. Ann Hematol. 94(Suppl 2):
S159–S165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Satlin MJ, Calfee DP, Chen L, Fauntleroy
KA, Wilson SJ, Jenkins SG, Feldman EJ, Roboz GJ, Shore TB, Helfgott
DC, et al: Emergence of carbapenem-resistant Enterobacteriaceae as
causes of bloodstream infections in patients with hematologic
malignancies. Leuk Lymphoma. 54:799–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Girmenia C, Rossolini GM, Piciocchi A,
Bertaina A, Pisapia G, Pastore D, Sica S, Severino A, Cudillo L,
Ciceri F, et al: Infections by carbapenem-resistant Klebsiella
pneumoniae in SCT recipients: A nationwide retrospective survey
from Italy. Bone Marrow Transplant. 50:282–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuckerman T, Benyamini N, Sprecher H,
Fineman R, Finkelstein R, Rowe JM and Oren I: SCT in patients with
carbapenem resistant Klebsiella pneumoniae: A single center
experience with oral gentamicin for the eradication of carrier
state. Bone Marrow Transplant. 46:1226–1230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuruvilla J, Forrest DL, Lavoie JC, Nantel
SH, Shepherd JD, Song KW, Sutherland HJ, Toze CL, Hogge DE and
Nevill TJ: Characteristics and outcome of patients developing
endocarditis following hematopoietic stem cell transplantation.
Bone Marrow Transplant. 34:969–973. 2004. View Article : Google Scholar : PubMed/NCBI
|
